New Neurodegeneration Challenge Network Puts Focus on Causes of Parkinson’s, Other Disorders

New Neurodegeneration Challenge Network Puts Focus on Causes of Parkinson’s, Other Disorders

A new network launched by Facebook CEO Mark Zuckerberg and his wife, Priscilla Chan, will unite leading investigators from various biomedical fields, as well as biologists and physicians, in gaining insight into why neurodegenerative disorders such as Parkinson’s occur.

The Chan Zuckerberg Initiative’s (CZI) Neurodegeneration Challenge Network will focus on neurodegenerative diseases as a group of disorders that share common features — and possibly future cures.

”Neurodegenerative disorders, including Alzheimer’s, Parkinson’s, Huntington’s disease and ALS, are a class of diseases that affect millions of people worldwide,” CZI science program officer Katja Brose said in a press release. “Meanwhile, the causes of most degenerative diseases are only partly understood, and there still are no effective therapies to cure, prevent or even treat most of these disorders.”

Research projects were selected in a competitive process. Grantees include 17 early-career investigators and nine collaborative teams. Each team — seven from the U.S, one from Sweden, and one from Belgium — will receive $1.05 million.

The Belgian team, led by Patrik Verstreken, PhD, plans to develop a new chip to study how Parkinson’s works. He will work alongside researchers Wim Vandenberghe, MD, PhD, and Dries Braeken, PhD.

”We will produce human neuronal microcircuits that are relevant to Parkinson’s disease on a multi-electrode array chip,” Braeken said. “This chip will be used to measure electrophysiological changes between neuronal circuits of cells obtained from healthy people and from an extensive collection of Parkinson’s patients.”

The 2D chip is needed to form a 3D human-relevant model for brain function and disorder.

Verstreken said he hopes to “print” small parts of the human brain on a unique chip, allowing scientists access to brain tissue from healthy individuals and patients. He explained that the technology can be used to monitor disease progression and to look for potential solutions.

”While we will develop this chip using tissue from Parkinson’s patients, the same technology can be used to create better models for Huntington’s disease or any other neurodegenerative disease, for that matter,” Vandenberghe said.

Years of research notwithstanding, there remains much about Parkinson’s and related diseases that scientists don’t yet understand.

“By supporting these nine interdisciplinary collaborations and generating shared tools, resources and platforms, we hope to inspire a new approach to tackling neurodegenerative disease — one that leverages the combined power of basic science and technology to accelerate progress toward clinical goals,” Brose said.

Zuckerberg is Facebook’s co-founder and CEO. Chan is a pediatrician and philanthropist. Founded by Zuckerberg and Chan in 2015, the CZI aims to use technology to solve some of the world’s toughest problems. Its focus areas are science, education, justice, and opportunity.

Mary Chapman Editor
Mary M. Chapman began her professional career at United Press International, running both print and broadcast desks. She then became a Michigan correspondent for what is now Bloomberg BNA, where she mainly covered the automotive industry plus legal, tax and regulatory issues. A member of the Automotive Press Association and one of a relatively small number of women on the car beat, Chapman has discussed the automotive industry multiple times of National Public Radio, and in 2014 was selected as an honorary judge at the prestigious Cobble Beach Concours d’Elegance. She has written for numerous national outlets including Time, People, Al-Jazeera America, Fortune, Daily Beast, MSN.com, Newsweek, The Detroit News and Detroit Free Press. The winner of the Society of Professional Journalists award for outstanding reporting, Chapman has had dozens of articles in The New York Times, including two on the coveted front page. She has completed a manuscript about centenarian car enthusiast Margaret Dunning, titled “Belle of the Concours.”
×
Mary Chapman Editor
Mary M. Chapman began her professional career at United Press International, running both print and broadcast desks. She then became a Michigan correspondent for what is now Bloomberg BNA, where she mainly covered the automotive industry plus legal, tax and regulatory issues. A member of the Automotive Press Association and one of a relatively small number of women on the car beat, Chapman has discussed the automotive industry multiple times of National Public Radio, and in 2014 was selected as an honorary judge at the prestigious Cobble Beach Concours d’Elegance. She has written for numerous national outlets including Time, People, Al-Jazeera America, Fortune, Daily Beast, MSN.com, Newsweek, The Detroit News and Detroit Free Press. The winner of the Society of Professional Journalists award for outstanding reporting, Chapman has had dozens of articles in The New York Times, including two on the coveted front page. She has completed a manuscript about centenarian car enthusiast Margaret Dunning, titled “Belle of the Concours.”
Latest Posts
  • Rock Steady Boxing conference
  • Parkinson’s Foundation Research Centers 
  • exercise program
  • Parkinson’s Foundation Research Centers 

4 comments

  1. Reijo Kivilehto says:

    I have studied Parkinson disease during 10 years. I think I have found out the mechanism of the disease. At least I have a convincing set of results to easen my situation. Now I feel better day after day.

    Impossible, one might say. I have written some reports to national organistation of P.D. patients. The reports / columns have been published in their magazine.

    • RobinK says:

      I applaud your efforts. Any pieces to this very complex and interrelated puzzle should be good news to the scientific community but especially to the PD Patient population. Don’t ever give up! Thank you

    • Noel D'Souza says:

      Thank you Mr. Reijo for enlightening us and wish you the very best. My friend of more than 5 decades is suffering from Parkinson’s. I am trying my best to help out but I cannot. Would be eternally grateful if you can shed some light on how to alleviate his condition particularly trembling and movement disorder ? My e-mail is [email protected]. I am based in Goa, the Western part of India. Thank you so much.

  2. Reijo Kivilehto says:

    I have also an objective to organize a root cause study by a questionnaire for patients. The answers would be analyzed and correlations found.

    I think that James Parkinson s “study on shaking palsy” needs an urgent update. Remember that study is now 201+ yaer old. Most of the neurodegenerative diseases must have the same ROOT CAUSE.

    sed on this idea I have been able to easen my situation. I feel a lot better than 2 years ago.

Leave a Comment

Your email address will not be published. Required fields are marked *